ReviewSurgical neurology international2024
Bow Hunter's syndrome surgical approach and outcome: Two new cases and literature review.
Review in Surgical neurology international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Bow hunter's syndrome secondary to lateral and posterior spondylosis: illustrative case.Journal of neurosurgery. Case lessons · 2026Article
- Bony Stroke: Clinical Features, Management, and Outcomes in a Case Series of Seven Patients.Cureus · 2026Article
- A Case of Bow Hunter's Syndrome Caused by C3/4 Facet Joint Hypertrophy: Hemodynamic Complexity and Surgical Strategy.NMC case report journal · 2026Article
- Passive Head Yawing as a Diagnostic Aid in Bow Hunter's Syndrome: A Rare Case of Bilateral Thrombosed Vertebral Artery Dissection Without Structural Compression.Annals of Indian Academy of Neurology · 2026Article
- Bow Hunter's syndrome on a persistent first intersegmental artery course in extreme old age: A case report.Surgical neurology international · 2026Article
- Endothelial senescence of the vertebral artery in the context of cervical degeneration: biomechanically driven remodeling of the hemodynamic environment.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Bow Hunter's syndrome (BHS) is a rare entity known as rotational vertebral artery occlusion syndrome. Classically, it presents with nausea, vertigo, and dizziness elicited by extension or rotation of the neck. There are several management approach modalities, including surgical and nonsurgical alternatives. Methods: We conducted an electronic database search on PubMed and Scopus. The search was performed on February 18, 2024, using a combination of keywords related to Bow Hunter Syndrome regarding management. From the latter query, 97 results followed, from which we included 76 and excluded 21 due to the information being irrelevant to our study and non-retrievable publications. Results: A total of 121 patients were retrieved. The mean age of presentation was 50 years, with a female-to-male ratio of 3:1. There were 108 adult cases, and only 13 were pediatric and adolescents. Symptoms were elicited by right rotation (46%). The most affected levels were C1-C2 (44%). The anterior approach was the most common (40%) and had a better outcome (84%), followed by the posterior (30%), which had more cases with partial recovery (19% vs. 16%). Conclusion: BHS management is still challenging as there are many factors that we must consider when deciding on the approach. There is inconclusive evidence on the proper management of these patients. Although the suggestions found in our review and our experience are valuable, no definitive management ensures a good quality of life and outcome for these patients. Further research is needed on this topic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.